Cancer Immunology and Immunotherapy
The recent FDA approval of Provenge® as the first therapeutic cancer vaccine together with the recent demonstration that Ipilimumab®, a monoclonal antibody that blocks the negative immune checkpoint cytotoxic T lymphocyte associated antigen-4, prolongs patient survival are major achievements that us...
Gardado en:
| Autor Corporativo: | |
|---|---|
| Outros autores: | |
| Formato: | Electrónico eBook |
| Idioma: | English |
| Publicado: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2011.
|
| Edición: | 1st ed. 2011. |
| Series: | Current Topics in Microbiology and Immunology,
344 |
| Subjects: | |
| Acceso en liña: | https://doi.org/10.1007/978-3-642-14136-2 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Sexa o primeiro en deixar un comentario!